273 related articles for article (PubMed ID: 24040362)
1. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
Zins K; Lucas T; Reichl P; Abraham D; Aharinejad S
PLoS One; 2013; 8(9):e74924. PubMed ID: 24040362
[TBL] [Abstract][Full Text] [Related]
2. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.
Zins K; Gunawardhana S; Lucas T; Abraham D; Aharinejad S
J Transl Med; 2013 Nov; 11():295. PubMed ID: 24279335
[TBL] [Abstract][Full Text] [Related]
3. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor.
Gao Y; Dickerson JB; Guo F; Zheng J; Zheng Y
Proc Natl Acad Sci U S A; 2004 May; 101(20):7618-23. PubMed ID: 15128949
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Rac activity alleviates lipopolysaccharide-induced acute pulmonary injury in mice.
Yao HY; Chen L; Xu C; Wang J; Chen J; Xie QM; Wu X; Yan XF
Biochim Biophys Acta; 2011 Jul; 1810(7):666-74. PubMed ID: 21511011
[TBL] [Abstract][Full Text] [Related]
5. Rac1 and Cdc42 GTPases regulate shear stress-driven β-catenin signaling in osteoblasts.
Wan Q; Cho E; Yokota H; Na S
Biochem Biophys Res Commun; 2013 Apr; 433(4):502-7. PubMed ID: 23524265
[TBL] [Abstract][Full Text] [Related]
6. Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma.
Kumar A; Al-Sammarraie N; DiPette DJ; Singh US
Oncotarget; 2014 Nov; 5(22):11709-22. PubMed ID: 25365944
[TBL] [Abstract][Full Text] [Related]
7. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
8. Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer.
Dokmanovic M; Hirsch DS; Shen Y; Wu WJ
Mol Cancer Ther; 2009 Jun; 8(6):1557-69. PubMed ID: 19509242
[TBL] [Abstract][Full Text] [Related]
9. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation.
Debidda M; Wang L; Zang H; Poli V; Zheng Y
J Biol Chem; 2005 Apr; 280(17):17275-85. PubMed ID: 15705584
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42.
Kücük P; Abbey L; Schmitt J; Henninger C; Fritz G
Pharmacol Res; 2024 May; 203():107165. PubMed ID: 38561112
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the GTPase Rac1 mediates the antimigratory effects of metformin in prostate cancer cells.
Dirat B; Ader I; Golzio M; Massa F; Mettouchi A; Laurent K; Larbret F; Malavaud B; Cormont M; Lemichez E; Cuvillier O; Tanti JF; Bost F
Mol Cancer Ther; 2015 Feb; 14(2):586-96. PubMed ID: 25527635
[TBL] [Abstract][Full Text] [Related]
12. Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase.
Zuo Y; Shields SK; Chakraborty C
Biochem Biophys Res Commun; 2006 Dec; 351(2):361-7. PubMed ID: 17064663
[TBL] [Abstract][Full Text] [Related]
13. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia/reoxygenation-experienced cancer cell migration and metastasis are regulated by Rap1- and Rac1-GTPase activation via the expression of thymosin beta-4.
Lee JW; Ryu YK; Ji YH; Kang JH; Moon EY
Oncotarget; 2015; 6(12):9820-33. PubMed ID: 25888632
[TBL] [Abstract][Full Text] [Related]
15. Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines.
Cardama GA; Comin MJ; Hornos L; Gonzalez N; Defelipe L; Turjanski AG; Alonso DF; Gomez DE; Menna PL
Anticancer Agents Med Chem; 2014; 14(6):840-51. PubMed ID: 24066799
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells.
Zhao Y; Wang Z; Jiang Y; Yang C
Cancer Lett; 2011 Dec; 313(1):54-63. PubMed ID: 21943825
[TBL] [Abstract][Full Text] [Related]
17. The human orthologue of CdGAP is a phosphoprotein and a GTPase-activating protein for Cdc42 and Rac1 but not RhoA.
Tcherkezian J; Triki I; Stenne R; Danek EI; Lamarche-Vane N
Biol Cell; 2006 Aug; 98(8):445-56. PubMed ID: 16519628
[TBL] [Abstract][Full Text] [Related]
18. Rac1/Cdc42 and RhoA GTPases antagonistically regulate chondrocyte proliferation, hypertrophy, and apoptosis.
Wang G; Beier F
J Bone Miner Res; 2005 Jun; 20(6):1022-31. PubMed ID: 15883643
[TBL] [Abstract][Full Text] [Related]
19. Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion.
Díaz J; Mendoza P; Ortiz R; Díaz N; Leyton L; Stupack D; Quest AF; Torres VA
J Cell Sci; 2014 Jun; 127(Pt 11):2401-6. PubMed ID: 24659799
[TBL] [Abstract][Full Text] [Related]
20. Blockade of Rac1 activity induces G1 cell cycle arrest or apoptosis in breast cancer cells through downregulation of cyclin D1, survivin, and X-linked inhibitor of apoptosis protein.
Yoshida T; Zhang Y; Rivera Rosado LA; Chen J; Khan T; Moon SY; Zhang B
Mol Cancer Ther; 2010 Jun; 9(6):1657-68. PubMed ID: 20515940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]